Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5226)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tamburrino D, Partelli S, Crippa S, Manzoni A, Maurizi A, Falconi M. Selection criteria in resectable pancreatic cancer: A biological and morphological approach. World J Gastroenterol 2014; 20(32): 11210-11215 [PMID: 25170205 DOI: 10.3748/wjg.v20.i32.11210] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v20/i32/11210.htm |
| Number | Citing Articles |
| 1 |
Maria Paola Belfiore, Francesco Michele Ronza, Francesco Romano, Giovanni Pietro Ianniello, Guido De Lucia, Concetta Gallo, Carmela Marsicano, Teresa Letizia Di Gennaro, Giuseppe Belfiore. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience. International Journal of Surgery 2015; 21: S34 doi: 10.1016/j.ijsu.2015.06.049
|
| 2 |
Barbara Grünwald, Jennifer Vandooren, Michael Gerg, Kaarin Ahomaa, Annique Hunger, Sonja Berchtold, Sophia Akbareian, Susanne Schaten, Percy Knolle, Dylan R. Edwards, Ghislain Opdenakker, Achim Krüger. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow. Molecular Cancer Research 2016; 14(11): 1147 doi: 10.1158/1541-7786.MCR-16-0180
|
| 3 |
Luís Ramalhete, Emanuel Vigia, Rúben Araújo, Hugo Pinto Marques. Proteomics-Driven Biomarkers in Pancreatic Cancer. Proteomes 2023; 11(3): 24 doi: 10.3390/proteomes11030024
|
| 4 |
Luke Wisniewski, Samuel Braak, Zachary Klamer, ChongFeng Gao, Chanjuan Shi, Peter Allen, Brian B. Haab. Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1135405
|
| 5 |
Madeline T. Olson, Quan P. Ly, Aaron M. Mohs. Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation. Molecular Imaging and Biology 2019; 21(2): 200 doi: 10.1007/s11307-018-1239-2
|
| 6 |
Suji Baek, Sanghee Nah, Joo Yeon Park, Sang Ju Lee, Yong Gil Kang, Seung Hae Kwon, Seung Jun Oh, Kang Pa Lee, Byung Seok Moon. A novel chalcone derivative exerts anticancer effects by promoting apoptotic cell death of human pancreatic cancer cells. Bioorganic & Medicinal Chemistry 2023; 93: 117458 doi: 10.1016/j.bmc.2023.117458
|
| 7 |
Gian Carlo Mattiucci, Alessio G. Morganti, Francesco Cellini, Milly Buwenge, Riccardo Casadei, Andrea Farioli, Sergio Alfieri, Alessandra Arcelli, Federica Bertini, Felipe A. Calvo, Silvia Cammelli, Lorenzo Fuccio, Lucia Giaccherini, Alessandra Guido, Joseph M. Herman, Gabriella Macchia, Bert W. Maidment, Robert C. Miller, Francesco Minni, William F. Regine, Michele Reni, Stefano Partelli, Massimo Falconi, Vincenzo Valentini. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Translational Oncology 2019; 12(1): 1 doi: 10.1016/j.tranon.2018.08.017
|
| 8 |
E. N. Kolesnikov, D. Ya. Iozefi, O. I. Kit, A. Yu. Maksimov. Magnetic resonance imaging relevance in diagnosis and prognosis of early postoperative period following pancreatic cancer surgical treatment. South Russian Journal of Cancer 2023; 4(4): 32 doi: 10.37748/2686-9039-2023-4-4-4
|
| 9 |
Stanislav John. Current perspective on the treatment of advanced pancreatic adenocarcinoma. Onkologie 2020; 14(1): 37 doi: 10.36290/xon.2020.010
|
| 10 |
Barbara Grünwald, Veronika Harant, Susanne Schaten, Monika Frühschütz, Ria Spallek, Bastian Höchst, Katharina Stutzer, Sonja Berchtold, Mert Erkan, Olga Prokopchuk, Marc Martignoni, Irene Esposito, Mathias Heikenwalder, Aayush Gupta, Jens Siveke, Paul Saftig, Percy Knolle, Dirk Wohlleber, Achim Krüger. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. Gastroenterology 2016; 151(5): 1011 doi: 10.1053/j.gastro.2016.07.043
|
| 11 |
S. Crippa, A. Bittoni, E. Sebastiani, S. Partelli, S. Zanon, A. Lanese, K. Andrikou, F. Muffatti, G. Balzano, M. Reni, S. Cascinu, M. Falconi. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?. European Journal of Surgical Oncology (EJSO) 2016; 42(10): 1533 doi: 10.1016/j.ejso.2016.06.398
|
| 12 |
Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, María Fernández Martínez, Pilar García-Alfonso, Andrés Muñoz Martin, Jose Manuel Asencio. Neoadjuvant therapy impact in early pancreatic cancer: “bioborderline” vs. “non-bioborderline”. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(4): 363 doi: 10.14701/ahbps.22-023
|
| 13 |
Faustino Mollinedo, Consuelo Gajate. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer. Cancers 2021; 13(16): 4173 doi: 10.3390/cancers13164173
|
| 14 |
Kyriaki Lekka, Evanthia Tzitzi, Alexander Giakoustidis, Vassilios Papadopoulos, Dimitrios Giakoustidis. Contemporary management of borderline resectable pancreatic ductal adenocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery 2019; 23(2): 97 doi: 10.14701/ahbps.2019.23.2.97
|
| 15 |
Leah K. Winer, Alexander R. Cortez, Syed A. Ahmad, Koffi Wima, Olubenga Olowokure, Tahir Latif, Jordan Kharofa, Sameer H. Patel. Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment. Journal of Surgical Research 2021; 259: 442 doi: 10.1016/j.jss.2020.09.009
|
| 16 |
J.W. Gilbert, B. Wolpin, T. Clancy, J. Wang, H. Mamon, A.B. Shinagare, J. Jagannathan, M. Rosenthal. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Annals of Oncology 2017; 28(9): 2067 doi: 10.1093/annonc/mdx180
|
| 17 |
Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Takafumi Akasu, Masayuki Saruta, Masato Okamoto, Hiroaki Kitamura, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Haruo Sugiyama, Shigeo Koido. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Cancer Investigation 2019; 37(9): 463 doi: 10.1080/07357907.2019.1661427
|
| 18 |
Elena Rangelova, Agnes Wefer, Saga Persson, Roberto Valente, Kimitaka Tanaka, Nicola Orsini, Ralf Segersvärd, Urban Arnelo, Marco Del Chiaro. Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer. Annals of Surgery 2021; 273(3): 579 doi: 10.1097/SLA.0000000000003301
|
| 19 |
P. Durie, J.-D. Baillargeon, S. Bouchard, F. Donnellan, S. Zepeda-Gomez, C. Teshima. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel. Current Medical Research and Opinion 2018; 34(1): 25 doi: 10.1080/03007995.2017.1389704
|
| 20 |
Andrew J. Hilmer, R. Brooke Jeffrey, Walter G. Park, Chaitan Khosla. Cholestyramine as a promising, strong anion exchange resin for direct capture of genetic biomarkers from raw pancreatic fluids. Biotechnology and Bioengineering 2017; 114(4): 934 doi: 10.1002/bit.26207
|
| 21 |
Shin Hye Hwang, Ha Yan Kim, Eun Ju Lee, Ho Kyoung Hwang, Mi-Suk Park, Myeong-jin Kim, Woo Jung Lee, Yong Eun Chung, Chang Moo Kang. Preoperative Clinical and Computed Tomography (CT)-Based Nomogram to Predict Oncologic Outcomes in Patients with Pancreatic Head Cancer Resected with Curative Intent: A Retrospective Study. Journal of Clinical Medicine 2019; 8(10): 1749 doi: 10.3390/jcm8101749
|
| 22 |
Toshihiko Masui, Kazuyuki Nagai, Takayuki Anazawa, Yosuke Kasai, Akitada Yogo, Michio Yoshimura, Takashi Mizowaki, Norimitsu Uza, Akihisa Fukuda, Shigemi Matsumoto, Masashi Kanai, Hiroyoshi Isoda, Yoshiya Kawaguchi, Shinji Uemoto, Etsuro Hatano. Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study. Cancer Medicine 2023; 12(18): 18611 doi: 10.1002/cam4.6470
|
| 23 |
Rossana Berardi, Silvia Rinaldi, Giulio Belfiori, Stefano Partelli, Stefano Crippa, Mariangela Torniai, Massimo Falconi. The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer. Clinical Medicine Insights: Oncology 2020; 14: 117955492093660 doi: 10.1177/1179554920936605
|
| 24 |
|
| 25 |
Aoi Hayasaki, Shuji Isaji, Masashi Kishiwada, Takehiro Fujii, Yusuke Iizawa, Hiroyuki Kato, Akihiro Tanemura, Yasuhiro Murata, Yoshinori Azumi, Naohisa Kuriyama, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai. Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer. Cancers 2018; 10(3): 65 doi: 10.3390/cancers10030065
|
| 26 |
Richard J. White, Shaakir Hasan, Dulabh Monga, Gene Finley, Mohammed Islam, Suzanne Schiffman, H. Kenneth Williams, Abhijit Kulkarni, Shyam Thakkar, Alexander V. Kirichenko, Rodney E. Wegner. Time to Adjuvant Systemic Therapy Following Pancreatic Cancer Resection and Effect on Outcome. Pancreas 2019; 48(8): 1086 doi: 10.1097/MPA.0000000000001373
|
| 27 |
Anna J. Boland, Anthony A. O’Kane, Richard Buick, Daniel B. Longley, Christopher J. Scott. Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188557 doi: 10.1016/j.bbcan.2021.188557
|
| 28 |
Ezzeddine Chouat, Alia Zehani, Ines Chelly, Manel Njima, Houcine Maghrebi, Mohammed Amine Bani, Leila Njim, Abdelfatteh Zakhama, Slim Haouet, Nidhameddine Kchir. Tumor budding is a prognostic factor linked to epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Study report and literature review. Pancreatology 2018; 18(1): 79 doi: 10.1016/j.pan.2017.11.010
|
| 29 |
Teena Dhir, Christopher W. Schultz, Aditi Jain, Samantha Z. Brown, Alex Haber, Austin Goetz, Chunhua Xi, Gloria H. Su, Liang Xu, James Posey, Wei Jiang, Charles J. Yeo, Talia Golan, Michael J. Pishvaian, Jonathan R. Brody. Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Molecular Cancer Research 2019; 17(10): 2029 doi: 10.1158/1541-7786.MCR-19-0589
|